New Global Head of Development for Daiichi Sankyo
September 7, 2016
Daiichi Sankyo, Inc. (Edison,NJ) announced the appointment of Marielle Cohard-Radice, M.D., as Executive Vice President, Global Head of Development.
In her new role, Dr. Cohard-Radice will have responsibility for the development strategy and portfolio planning for the Cardiovascular-Metabolism and Internal Medicine therapeutic areas.
Prior to her promotion, Marielle Cohard-Radice was Vice President of Clinical Development Operations at Daiichi Sankyo Pharma Development, a position she held since 2012.
The former Global Head of Development, Mahmoud Ghazzi, M.D., Ph.D, has decided to leave the company.
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
